Oxadiazoles
![Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242673.png-250.jpg)
Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 5 MG
PSN 375963 is a small-molecule agonist of G protein-coupled receptor 119 (GPR119) used as a research tool to probe GPR119 signaling and metabolic pathways. It is reported with low micromolar activity and is provided as a solid suitable for biochemical and cellular assays.
- Potent GPR119 agonist with EC50 ≈ 8.4 μM (human) and 7.9 μM (mouse).
- Small molecule with formula C17H23N3O and molecular weight 285.38 g·mol⁻¹.
- Supplied as a solid suitable for biochemical and cellular assays.
- High reported purity (99.96%).
- Used to study GPR119-mediated metabolic signaling and receptor pharmacology.
Medchemexpress LLC 1-bromo-4-(bromomethyl)benzene-d6 | 229948-68-9 | MFCD22565819 | 99.6% | 255.97 | C7D6Br2 | 10 MG
1-Bromo-4-(bromomethyl)benzene-d6 is a deuterium-labeled benzyl bromide supplied as a powder for research use. It is used as an isotopically labeled standard and synthetic intermediate in organic and medicinal chemistry, offering high purity for analytical and synthetic workflows.
- Deuterium-labeled benzyl bromide for use as an isotopically labeled standard.
- Molecular formula C7D6Br2 and molecular weight 255.97.
- High purity (99.56%) suitable for analytical applications.
- Supplied as a powder with recommended cold storage for stability.
- Available in small milligram quantities for research-scale use.
Medchemexpress LLC A synthetic superoxide dismutase and catalase mimetic | 81065-76-1 | 98.3% | 416.74 | C18H18ClMnN2O4 | 50 MG
EUK-134 is a synthetic small-molecule antioxidant with combined superoxide dismutase and catalase mimetic activity. It is supplied as a high-purity solid for research use in cell and animal models to investigate oxidative stress, mitochondrial protection, and related signaling pathways.
- Catalytically scavenges reactive oxygen species (ROS).
- Exhibits superoxide dismutase and catalase mimetic activity.
- Used in vitro and in vivo to study oxidative stress and mitochondrial function.
- High purity suitable for biochemical and cellular assays.
- Supplied as 50 mg solid for laboratory use.
eMolecules 1,3,4-Oxadiazol-2-ol | Combi-Blocks, Inc. | 51517-09-0 | MFCD26938312 | 86.050 | C2H2N2O2 | 98.000 | Oc1nnco1 | 250mg | 603153992
1,3,4-Oxadiazol-2-ol | Combi-Blocks, Inc. | 51517-09-0 | MFCD26938312 | 86.050 | C2H2N2O2 | 98.000 | Oc1nnco1 | 250mg | 603153992
Medchemexpress LLC 1,3,4-oxadiazole | 288-99-3 | MFCD00955535 | 99.8% | 70.05 g/mol | C2H2N2O | 250 MG
1,3,4-Oxadiazole is a small heterocyclic compound commonly used as a building block and intermediate in medicinal chemistry and chemical research. The material is supplied as a high-purity research sample in milligram to gram pack sizes and is characterized by a low molecular weight and simple ring structure.
- Purity 99.8%.
- Molecular formula C2H2N2O; molecular weight 70.05 g/mol.
- Appearance colorless to light yellow liquid (density ~0.97 g/cm3).
- Suitable as a synthetic building block for medicinal chemistry applications.
- Storage recommendations: pure form stable at -20°C for extended periods; shorter stability in solution.
- Available in mg and g pack sizes, including 250 MG.
eMolecules 4-(1,3,4-Oxadiazol-2-yl)phenol | 5378-27-8 | MFCD00221056 | 1g
Combi-Blocks | 4-(1,3,4-Oxadiazol-2-yl)phenol | 1g | 117568897 | ST-2112 | 98.000 | 5378-27-8 | MFCD00221056 | 162.148 | C8H6N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | 99.8% | 187.16 g/mol | C9H5N3O2 | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000211707.png-250.jpg)
Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | 99.8% | 187.16 g/mol | C9H5N3O2 | 1 ML
ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) is a potent, selective inhibitor of soluble guanylyl cyclase (sGC) used in research to probe nitric oxide-cGMP signaling and related cellular processes. It is supplied in solution and solid formats for biochemical and cell-based studies.
- Potent and selective inhibitor of soluble guanylyl cyclase (sGC).
- Useful for studying nitric oxide-cGMP signaling in biochemical and cell-based assays.
- Enhances pro-apoptotic effects of cisplatin in certain cell models.
- Available as a 10 mM solution in DMSO (1 mL) and in multiple solid sizes.
- High purity (~99.8%) suitable for research applications.
![Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242681.png-250.jpg)
Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 100 MG
PSN 375963 is a small-molecule agonist of the G protein-coupled receptor GPR119 used as a research tool for in vitro pharmacology. It exhibits micromolar potency and is provided with supporting analytical documentation for use in biochemical and cell-based assays.
- Shows micromolar agonist activity at GPR119 (EC50s 8.4 μM human, 7.9 μM mouse).
- Supplied as a characterized research-grade compound with COA and SDS.
- Available as solid powder and DMSO solutions for assay flexibility.
- High purity suitable for biochemical and cell-based assays.
- Molecular formula C17H23N3O and molecular weight 285.38 g·mol⁻¹.
Medchemexpress LLC PSN 375963 10mg | 388575-52-8 | 10MG
PSN 375963 is a potent GPR119 agonist with EC50s of 8 4 and 7 9 M for human and mouse GPR119 respectively PSN 375963 shows similar potency to the endogenous agonist oleoylethanolamide (OEA)[1 [2
![Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | >98.0% | 187.16 | C9H5N3O2 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000211708.png-250.jpg)
Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | >98.0% | 187.16 | C9H5N3O2 | 5 MG
ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) is a potent, selective inhibitor of soluble guanylyl cyclase (sGC) used as a research reagent in biochemical and cell-based studies. It blocks NO-activated sGC activity and has been reported to enhance the pro-apoptotic effects of cisplatin in certain cancer cell models. Supplied as a powder for preparation of stock solutions, it is intended for research use only.
- Potent, selective inhibitor of soluble guanylyl cyclase.
- Useful tool compound for studying nitric oxide-sGC signaling.
- Reported to enhance cisplatin-induced apoptosis in some cell models.
- Supplied as a powder suitable for preparing concentrated stock solutions.
- Stable with defined storage recommendations for powder and solutions.